You are here: All Products  > Gracell Reports Positive Data from Trial of BCMA/CD19 FasTCAR-T in Multiple Myeloma

Gracell Reports Positive Data from Trial of BCMA/CD19 FasTCAR-T in Multiple Myeloma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products